Adaptive Biotechnologies ... (ADPT)
undefined
undefined%
At close: undefined
6.30
0.08%
After-hours Dec 13, 2024, 06:08 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17
Net Income -225.25M -200.37M -207.30M -146.23M -68.61M -46.45M -42.83M
Depreciation & Amortization 22.23M 20.92M 13.95M 8.47M 7.79M 6.00M 5.80M
Stock-Based Compensation 62.91M 55.48M 43.25M 24.76M 13.12M 11.15M 7.01M
Other Working Capital -44.20M -56.83M -49.48M -43.66M 266.41M -1.32M 1.49M
Other Non-Cash Items 29.97M 11.57M 6.95M 3.34M 43.00K 5.00K 6.00K
Deferred Income Tax - - 7.23M 773.00K -1.88M -1.24M 637.00K
Change in Working Capital -46.18M -71.55M -56.82M -40.80M 254.93M -1.72M -5.47M
Operating Cash Flow -156.32M -183.94M -192.73M -149.68M 205.40M -32.26M -34.86M
Capital Expenditures -10.70M -16.35M -61.75M -18.80M -11.20M -6.32M -2.51M
Acquisitions - -19.25M -181.21M 98.24M 470.50M 19.00K 85.00K
Purchase of Investments -429.56M -278.78M -316.54M -694.97M -884.22M -146.50M -125.18M
Sales Maturities Of Investments 569.90M 298.03M 559.50M 596.72M 413.72M 153.54M 163.91M
Other Investing Acitivies -1 19.25M 181.21M -98.24M -470.50M 19.00K 122.00K
Investing Cash Flow 129.65M 2.90M 181.21M -117.04M -481.70M 736.00K 36.43M
Debt Repayment - 124.38M - - - - -
Common Stock Repurchased - - - - - - -
Dividend Paid - - - - - - -
Other Financial Acitivies 2.25M 7.89M 27.15M 21.43M -934.00K 1.25M 50.03M
Financial Cash Flow 2.25M 132.26M 27.15M 293.59M 319.92M 1.25M 50.03M
Net Cash Flow -24.43M -48.77M 15.63M 26.86M 43.62M -30.27M 51.61M
Free Cash Flow -167.02M -200.29M -254.47M -168.49M 194.20M -38.58M -37.36M